Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.0%

1 terminated out of 25 trials

Success Rate

94.7%

+8.2% vs benchmark

Late-Stage Pipeline

16%

4 trials in Phase 3/4

Results Transparency

6%

1 of 18 completed with results

Key Signals

1 with results95% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (6)
P 1 (2)
P 2 (1)
P 4 (4)

Trial Status

Completed18
Recruiting2
Unknown2
Withdrawn1
Terminated1
Not Yet Recruiting1

Trial Success Rate

94.7%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07275541RecruitingPrimary

Platelet Aggregation in the Diagnosis of Acute Graft Rejection

NCT05702463Phase 1RecruitingPrimary

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

NCT07203846Phase 4Not Yet Recruiting

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

NCT06236243Not ApplicableCompleted

Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults

NCT03528603Not ApplicableCompletedPrimary

Acute Assessment of Platelet Reactivity After the Intake of Oleocanthal

NCT05581238CompletedPrimary

Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.

NCT04842760Unknown

PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer

NCT03121378Completed

Multiple Electrode Aggregometry to Assess Platelet Function in Patients Undergoing Hip Joint Alloplasty With and Without Bone Cement

NCT03355625Completed

Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients

NCT03615846UnknownPrimary

Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan

NCT02958657Not ApplicableCompletedPrimary

Effect of Exercise on Platelet Reactivity After Myocardial Infarction

NCT04492423Completed

VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study

NCT04369534Phase 4Completed

Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction

NCT03039205Phase 2CompletedPrimary

Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor

NCT03716310Completed

Platelet Reactivity in Septic Shock

NCT00748371Phase 4TerminatedPrimary

Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration

NCT02112539CompletedPrimary

Aggreguide A-100 ADP Assay Evaluation

NCT01815008Phase 4CompletedPrimary

Pharmacogenomics of Antiplatelet Response - I

NCT00942617Not ApplicableWithdrawnPrimary

Measurement of Platelet Dense Granule Release in Healthy Volunteers

NCT00233428CompletedPrimary

Study to Determine Racial and Gender Differences in Platelet Aggregation

Scroll to load more

Research Network

Activity Timeline